Instil Bio
64 hedge funds and large institutions have $1.28B invested in Instil Bio in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $1.35B → $1.28B (-$61.6M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
64
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$30.4M | |
| 2 | +$2.28M | |
| 3 | +$1.75M | |
| 4 |
E
Ergoteles
New York
|
+$1.43M |
| 5 |
PM
Parametrica Management
Wanchai,
Hong Kong
|
+$826K |
Top Sellers
| 1 | -$7.5M | |
| 2 | -$3.1M | |
| 3 | -$1.08M | |
| 4 |
Morgan Stanley
New York
|
-$892K |
| 5 |
D.E. Shaw & Co
New York
|
-$820K |